Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 229
7
Diseases
44
Unique genes
0.258
Avg. similarity score
Congenital epicanthus
Most-connected disease (5 links)
Disease
Searched: fibrodysplasia ossificans progressiva
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
fibrodysplasia ossificans progressiva
Congenital epicanthus
ATP1A3-associated neurological disorder
Capos syndrome
Cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss
Alternating hemiplegia of childhood
Esophageal atresia
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Congenital epicanthus | 5 | 5 | 14 |
| ATP1A3-associated neurological disorder | 4 | 4 | 1 |
| Capos syndrome | 4 | 4 | 1 |
| Cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss | 4 | 4 | 1 |
| Alternating hemiplegia of childhood | 3 | 3 | 2 |
| Esophageal atresia | 1 | 1 | 32 |
| fibrodysplasia ossificans progressiva | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| ATP1A3 | 6 / 7 | Alternating hemiplegia of childhood, ATP1A3-associated neurological disorder, Capos syndrome, Cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss and 2 more |
| ACVR1 | 2 / 7 | Congenital epicanthus, fibrodysplasia ossificans progressiva |
| KCNA6 | 2 / 7 | Congenital epicanthus, Esophageal atresia |
| TCF4 | 2 / 7 | Congenital epicanthus, Esophageal atresia |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Insulin secretion | KEGG | 4 / 86 | 12.7× | 2.67e-4 | 4.80e-3 ✓ sig. |
| Cardiac muscle contraction | KEGG | 4 / 87 | 12.5× | 2.80e-4 | 4.96e-3 ✓ sig. |
| cGMP-PKG signaling pathway | KEGG | 5 / 166 | 8.2× | 3.34e-4 | 5.72e-3 ✓ sig. |
| Aldosterone-regulated sodium reabsorption | KEGG | 3 / 38 | 21.5× | 3.54e-4 | 6.01e-3 ✓ sig. |
| Leukocyte transendothelial migration | KEGG | 4 / 116 | 9.4× | 8.33e-4 | 1.16e-2 ✓ sig. |
| Ion homeostasis | Reactome | 3 / 54 | 15.2× | 9.99e-4 | 1.34e-2 ✓ sig. |
| Thyroid hormone signaling pathway | KEGG | 4 / 122 | 8.9× | 1.01e-3 | 1.35e-2 ✓ sig. |
| Adrenergic signaling in cardiomyocytes | KEGG | 4 / 154 | 7.1× | 2.37e-3 | 2.58e-2 ✓ sig. |
| Proximal tubule bicarbonate reclamation | KEGG | 2 / 23 | 23.7× | 3.16e-3 | 3.18e-2 ✓ sig. |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | Reactome | 2 / 23 | 23.7× | 3.16e-3 | 3.18e-2 ✓ sig. |
| Interleukin-20 family signaling | Reactome | 2 / 25 | 21.8× | 3.73e-3 | 3.57e-2 ✓ sig. |
| Insulin receptor recycling | Reactome | 2 / 26 | 21.0× | 4.03e-3 | 3.78e-2 ✓ sig. |
| Downstream signal transduction | Reactome | 2 / 29 | 18.8× | 5.00e-3 | 4.37e-2 ✓ sig. |
| MET activates PTK2 signaling | Reactome | 2 / 30 | 18.2× | 5.35e-3 | 4.58e-2 ✓ sig. |
| Aldosterone synthesis and secretion | KEGG | 3 / 98 | 8.4× | 5.48e-3 | 4.65e-2 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| potassium ion transport | GO:0006813 | 6 / 152 | 16.8× | 1.43e-6 | 1.11e-4 ✓ sig. |
| cell communication by electrical coupling involved in cardiac conduction | GO:0086064 | 3 / 12 | 106× | 2.64e-6 | 1.81e-4 ✓ sig. |
| negative regulation of anoikis | GO:2000811 | 3 / 19 | 67.1× | 1.15e-5 | 5.85e-4 ✓ sig. |
| potassium ion transmembrane transport | GO:0071805 | 5 / 150 | 14.2× | 2.63e-5 | 1.11e-3 ✓ sig. |
| heart development | GO:0007507 | 6 / 273 | 9.3× | 4.08e-5 | 1.55e-3 ✓ sig. |
| positive regulation of cardiac epithelial to mesenchymal transition | GO:0062043 | 2 / 5 | 170× | 5.39e-5 | 1.91e-3 ✓ sig. |
| regulation of developmental process | GO:0050793 | 3 / 32 | 39.8× | 5.76e-5 | 2.01e-3 ✓ sig. |
| positive regulation of autophagy | GO:0010508 | 4 / 92 | 18.5× | 6.42e-5 | 2.18e-3 ✓ sig. |
| negative regulation of heart contraction | GO:0045822 | 2 / 6 | 142× | 8.08e-5 | 2.59e-3 ✓ sig. |
| response to glycoside | GO:1903416 | 2 / 6 | 142× | 8.08e-5 | 2.59e-3 ✓ sig. |
| ATP metabolic process | GO:0046034 | 3 / 36 | 35.4× | 8.24e-5 | 2.63e-3 ✓ sig. |
| integrin-mediated signaling pathway | GO:0007229 | 4 / 100 | 17.0× | 8.89e-5 | 2.78e-3 ✓ sig. |
| positive regulation of D-glucose import | GO:0046326 | 3 / 38 | 33.5× | 9.70e-5 | 2.96e-3 ✓ sig. |
| positive regulation of bone mineralization | GO:0030501 | 3 / 42 | 30.3× | 1.31e-4 | 3.72e-3 ✓ sig. |
| positive regulation of intracellular signal transduction | GO:1902533 | 3 / 43 | 29.6× | 1.41e-4 | 3.91e-3 ✓ sig. |